SMTL ID : 3cs9.1 (3 other biounits)

Human ABL kinase in complex with nilotinib

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.21 Å

Oligo State

monomer

Ligands

1 x NIL: Nilotinib(Non-covalent)

NIL.1: 24 residues within 4Å: Chain A: L.25, Y.30, V.33, A.46, K.48, K.62, E.63, V.66, M.67, I.70, L.75, V.76, I.90, T.92, F.94, M.95, G.98, F.136, H.138, L.147, V.156, A.157, D.158, F.159 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:L.25, A:Y.30, A:A.46, A:K.62, A:E.63, A:V.66, A:I.90, A:T.92, A:L.147, A:D.158, A:F.159 Hydrogen bonds: A:E.63, A:T.92, A:M.95, A:D.158 pi-Stacking: A:Y.30

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Weisberg, E. et al., Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell (2005)

Release Date

2008-04-22

Peptides

Proto-oncogene tyrosine-protein kinase ABL1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Proto-oncogene tyrosine-protein kinase ABL1

Related Entries With Identical Sequence